174 related articles for article (PubMed ID: 23410740)
1. An attempt to develop mouse model for anti-laminin γ1 pemphigoid.
Koga H; Ishii N; Dainichi T; Tsuruta D; Hamada T; Ohata C; Karashima T; Furumura M; Hashimoto T
J Dermatol Sci; 2013 May; 70(2):108-15. PubMed ID: 23410740
[TBL] [Abstract][Full Text] [Related]
2. Pathogenicity of autoantibodies in anti-p200 pemphigoid.
Vafia K; Groth S; Beckmann T; Hirose M; Dworschak J; Recke A; Ludwig RJ; Hashimoto T; Zillikens D; Schmidt E
PLoS One; 2012; 7(7):e41769. PubMed ID: 22911854
[TBL] [Abstract][Full Text] [Related]
3. Anti-p200 pemphigoid.
Goletz S; Hashimoto T; Zillikens D; Schmidt E
J Am Acad Dermatol; 2014 Jul; 71(1):185-91. PubMed ID: 24767733
[TBL] [Abstract][Full Text] [Related]
4. From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid.
Dainichi T; Koga H; Tsuji T; Ishii N; Ohyama B; Ueda A; Natsuaki Y; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
J Dermatol; 2010 Mar; 37(3):231-8. PubMed ID: 20507386
[TBL] [Abstract][Full Text] [Related]
5. IgA anti-p200 pemphigoid.
Wozniak K; Hashimoto T; Fukuda S; Ohyama B; Ishii N; Koga H; Dainichi T; Kowalewski C
Arch Dermatol; 2011 Nov; 147(11):1306-10. PubMed ID: 22106117
[TBL] [Abstract][Full Text] [Related]
6. Human anti-laminin 5 autoantibodies induce subepidermal blisters in an experimental human skin graft model.
Lazarova Z; Hsu R; Yee C; Yancey KB
J Invest Dermatol; 2000 Jan; 114(1):178-84. PubMed ID: 10620135
[TBL] [Abstract][Full Text] [Related]
7. Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.
Meijer JM; Diercks GF; Schmidt E; Pas HH; Jonkman MF
JAMA Dermatol; 2016 Aug; 152(8):897-904. PubMed ID: 27167149
[TBL] [Abstract][Full Text] [Related]
8. Anti-laminin gamma-1 pemphigoid.
Dainichi T; Kurono S; Ohyama B; Ishii N; Sanzen N; Hayashi M; Shimono C; Taniguchi Y; Koga H; Karashima T; Yasumoto S; Zillikens D; Sekiguchi K; Hashimoto T
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2800-5. PubMed ID: 19196964
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of anti-laminin γ-1 pemphigoid by immunoblot analysis.
Solimani F; Pollmann R; Ishii N; Eming R; Hashimoto T; Schmidt T; Hertl M
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):735-741. PubMed ID: 29972879
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo pathogenicity of anti-laminin γ1 autoantibodies.
Florea F; Bernards C; Caproni M; Kleindienst J; Hashimoto T; Koch M; Sitaru C
Am J Pathol; 2014 Feb; 184(2):494-506. PubMed ID: 24300951
[TBL] [Abstract][Full Text] [Related]
11. Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice.
Lazarova Z; Yee C; Darling T; Briggaman RA; Yancey KB
J Clin Invest; 1996 Oct; 98(7):1509-18. PubMed ID: 8833897
[TBL] [Abstract][Full Text] [Related]
12. Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoid.
Groth S; Recke A; Vafia K; Ludwig RJ; Hashimoto T; Zillikens D; Schmidt E
Br J Dermatol; 2011 Jan; 164(1):76-82. PubMed ID: 20854435
[TBL] [Abstract][Full Text] [Related]
13. Fab fragments directed against laminin 5 induce subepidermal blisters in neonatal mice.
Lazarova Z; Hsu R; Briggaman RA; Yancey KB
Clin Immunol; 2000 Apr; 95(1 Pt 1):26-32. PubMed ID: 10794429
[TBL] [Abstract][Full Text] [Related]
14. [Anti-p200 pemphigoid: a spectacular response to dapsone].
Munsch C; Prey S; Joly P; Meyer N; Lamant L; Livideanu C; Viraben R; Paul C
Ann Dermatol Venereol; 2011 Nov; 138(11):739-42. PubMed ID: 22078034
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of immunofluorescence overlay antigen mapping in the identification of autoantigen in anti-p200 pemphigoid.
Kitayama S; Makino T; Hayashi M; Mizawa M; Ishii N; Hashimoto T; Shimizu T
J Dermatol; 2023 Sep; 50(9):1194-1198. PubMed ID: 37082790
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
17. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
[TBL] [Abstract][Full Text] [Related]
18. [Anti-p200 pemphigoid].
Holtsche MM; Goletz S; Zillikens D
Hautarzt; 2019 Apr; 70(4):271-276. PubMed ID: 30868255
[TBL] [Abstract][Full Text] [Related]
19. Pemphigoid with antibodies to laminin γ1, BP180 and BP230, associated with psoriasis vulgaris: successful disease control with cyclosporin.
Imanishi A; Tateishi C; Imanishi H; Sowa-Osako J; Koga H; Tsuruta D; Hashimoto T
J Dermatol; 2015 Apr; 42(4):394-7. PubMed ID: 25708520
[TBL] [Abstract][Full Text] [Related]
20. [Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)].
Raffin D; Delaplace M; Roussel A; Estève E
Ann Dermatol Venereol; 2013 Dec; 140(12):784-7. PubMed ID: 24315224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]